epstein-index / content-documents /house-oversight-nov /13 /HOUSE_OVERSIGHT_024634.md
robbd's picture
seed: site content tree, sharded for HF dir limits
af43568 verified
|
Raw History Blame
1.77 kB
metadata
title: 'House Oversight: Estate Documents (Nov 12) (HOUSE_OVERSIGHT_024634)'
source: 'House Oversight: Estate Documents (Nov 12)'
sourceUrl: https://www.justice.gov/epstein
date: '2026-01-01'
category: House Oversight
eftaNumber: HOUSE_OVERSIGHT_024634
ocrPages: 1
ocrChars: 1207
ocrElapsed: 0
parseTier: external-legacy
engine: engine undisclosed (ep-nov-12.greg.technology mirror)
externalSource: greg-ep-nov-12
externalLicense: not granted
externalCredit: ep-nov-12.greg.technology
externalUrl: https://ep-nov-12.greg.technology

$140,000 $120,000 $100,000 $80,000 $60,000 $40,000 U.S. Legalized Cannabis Market Path to Federal Legalization FDA Approves Cannabis-Derived Pharmaceuticals More States Adopt Medical Cannabis Laws More States Adopt Recreational Laws FDA Routinely Approves CBD Drugs FDA Routinely Approves THC Drugs Federal Government Legalizes Cannabis $20.000 So sore 3017 2018

  • 70 M 60 M
  • 50 M
  • 40 M
  • 30 M
  • 20 M
  • 10 M 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 M Legalized Cannabis Market Size Consumers Source: Ackrell Capital. Assumes cannabis will be legalized federally by 2027. Cannabis may never be legalized federally in the United States. Number of Consumers Cannabis Industry Segments Cultivation Dispensaries Production Production Equipment and Supplies Distribution E-Commerce Production and Testing Services Business Solutions Business Software Flower Distribution Services Consumer Products Infused Products Concentrates Involves "touching the plant" Business Services Digital Media Online Content and Networking Online Directories Vaporizers and Accessories Pharmaceuticals Does not involve "touching the plant" © 2017 Ackrell Capital, LLC | Member FINRA/SIPC HOUSE_OVERSIGHT_024634